トランスクリプトミクス技術市場：技術、用途、エンドユーザー別-2025-2030年の世界予測

トランスクリプトミクス技術市場は、2023年に75億米ドルと評価され、2024年には84億8,000万米ドルに達すると予測され、CAGR 13.16％で成長し、2030年には178億3,000万米ドルになると予測されています。

トランスクリプトミクス技術先進のシーケンス技術を駆使して、特定の状況下でゲノムが生成するRNA転写物の包括的な研究を包含します。mRNA解析、ノンコーディングRNA、遺伝子発現プロファイリングを含み、遺伝子機能、制御、相互作用に関する洞察を可能にします。これらの技術は、環境変化、疾患、治療に対するダイナミックな細胞応答を明らかにする能力により、疾患診断、医薬品開発、個別化医療を支援するために不可欠です。その応用範囲はバイオテクノロジー、医薬品、臨床診断、学術・研究部門に及ぶ。同市場は、シーケンシング・プラットフォーム、バイオ計算手法の進歩、遺伝性疾患や慢性疾患の罹患率の増加により、精密な遺伝子解析の需要が高まっています。シングルセル・トランスクリプトミクスと空間トランスクリプトミクスの革新は、より詳細な細胞分析を可能にし、生物医学研究の限界を押し広げる有望な機会を示しています。これらの分野に参入する企業は、増大する研究ニーズに対応し、最先端の治療介入を開発することができます。しかし、市場の成長は、高いコスト、技術的な複雑さ、データのプライバシーに関する懸念によって制限されています。さらに、充実したバイオインフォマティクス・インフラや熟練した人材の必要性などの課題が、特に新興国市場での市場拡大を妨げています。潜在能力を活用し、これらの課題を克服するためには、技術プロバイダーとバイオテクノロジー企業間の協力関係の強化が推奨されます。費用対効果とデータ分析の継続的な改善は、特に個別化医療において勢いを維持し最終用途を拡大する上で極めて重要です。競合情勢は、戦略的パートナーシップ、研究開発への投資、倫理的なデータ活用への注力から大きな恩恵を受け、持続可能な市場プレゼンスへの道筋を提供します。最前線であり続けるために、企業はエンドユーザー向けの技術の簡素化、データ解釈ツールの改善、分析におけるAIの統合に注力し、プロセスを合理化してさらなるイノベーションを促進すべきです。

市場力学：急速に進化するトランスクリプトミクス技術市場の主要市場インサイトを公開

トランスクリプトミクス技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • メーカーとエンドユーザーの双方による個別化医薬品への嗜好の高まり
  • 慢性疾患の有病率の上昇
  • 新製品の承認と発売
• 市場抑制要因
  • トランスクリプトミクス技術に関連する高コスト
• 市場機会
  • 製品の継続的な技術進歩
  • トキシコゲノミクスにおけるトランスクリプトミクスの応用
• 市場の課題
  • トランスクリプトミクス技術におけるデータ管理の問題

ポーターの5つの力：トランスクリプトミクス技術市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、トランスクリプトミクス技術市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：トランスクリプトミクス技術市場における外部からの影響の把握

外部マクロ環境要因は、トランスクリプトミクス技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析トランスクリプトミクス技術市場における競合情勢の把握

トランスクリプトミクス技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックストランスクリプトミクス技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、トランスクリプトミクス技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨トランスクリプトミクス技術市場における成功への道筋を描く

トランスクリプトミクス技術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • メーカーとエンドユーザーの両方でパーソナライズされた医薬品への関心が高まっている
    • 慢性疾患の有病率の上昇
    • 新製品の承認と発売
  • 抑制要因
    • トランスクリプトミクス技術に関連する高コスト
  • 機会
    • 製品における継続的な技術進歩
    • 毒性ゲノミクスにおけるトランスクリプトミクスの応用
  • 課題
    • トランスクリプトミクス技術のデータ管理の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 トランスクリプトミクス技術市場：技術別

• 遺伝子制御技術
• マイクロアレイ
• 次世代シーケンシング
• PCR

第7章 トランスクリプトミクス技術市場：用途別

• バイオインフォマティクス
• 臨床診断
• 比較トランスクリプトミクス
• 医薬品の発見と調査

第8章 トランスクリプトミクス技術市場：エンドユーザー別

• 学術調査
• 製薬・バイオテクノロジー企業

第9章 南北アメリカのトランスクリプトミクス技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のトランスクリプトミクス技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのトランスクリプトミクス技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies Inc.
• Bio-Rad Laboratories, Inc.
• BioMerieux SA
• Cenix BioScience GmbH
• Danaher Corporation
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd
• GenXPro GmbH
• Illumina Inc.
• LC Sciences LLC
• Lexogen GmbH
• Promega Corporation
• Qiagen N. V.
• Sequentia Biotech SL
• Sigma Aldrich Corporation
• Takara Holdings, Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. TRANSCRIPTOMICS TECHNOLOGIES MARKET RESEARCH PROCESS
• FIGURE 2. TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSCRIPTOMICS TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSCRIPTOMICS TECHNOLOGIES MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GENE REGULATION TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. POLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. QATAR TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

The Transcriptomics Technologies Market was valued at USD 7.50 billion in 2023, expected to reach USD 8.48 billion in 2024, and is projected to grow at a CAGR of 13.16%, to USD 17.83 billion by 2030.

Transcriptomics technologies encompass the comprehensive study of RNA transcripts generated by the genome under specific circumstances using advanced sequencing technologies. The scope includes mRNA analysis, non-coding RNA, and gene expression profiling, enabling insights into gene function, regulation, and interaction. These technologies are essential due to their ability to reveal dynamic cellular responses to environmental changes, diseases, and treatments, thereby aiding in disease diagnosis, drug development, and personalized medicine. Applications extend across biotechnology, pharmaceuticals, clinical diagnostics, and academic and research sectors. The market is buoyed by advancements in sequencing platforms, biocomputational methods, and the increasing incidence of genetic and chronic diseases, driving demand for precise genetic analysis. Innovations in single-cell transcriptomics and spatial transcriptomics represent promising opportunities, enabling more detailed cellular analysis and pushing the boundaries of biomedical research. Companies tapping into these arenas can better cater to growing research needs and develop cutting-edge therapeutic interventions. However, market growth is restricted by high costs, technical complexities, and data privacy concerns. Additionally, challenges such as the requirement for substantial bioinformatics infrastructure and skilled personnel impede market expansion, particularly in developing regions. Enhanced collaborations between technology providers and biotechnology firms are recommended to harness potential and overcome these challenges. Continuous improvements in cost-effectiveness and data analytics will be crucial to maintain momentum and expand end-use applications, especially in personalized medicine. The competitive landscape benefits significantly from strategic partnerships, investment in R&D, and a focus on ethical data usage which offers a pathway to sustainable market presence. To remain at the forefront, businesses should focus on simplifying technology for end-users, improving data interpretation tools, and integrating AI in analytics to streamline processes and foster further innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transcriptomics Technologies Market

The Transcriptomics Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing preference for personalized medicines by both manufacturers and end-users
  • Rising prevalence of chronic disorders
  • Approval and launch of new products
• Market Restraints
  • High cost associated with transcriptomics technologies
• Market Opportunities
  • Continuous technological advancements in products
  • Applications of transcriptomics in toxicogenomics
• Market Challenges
  • Data management issues in transcriptomics technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transcriptomics Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transcriptomics Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transcriptomics Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transcriptomics Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transcriptomics Technologies Market

A detailed market share analysis in the Transcriptomics Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transcriptomics Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transcriptomics Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transcriptomics Technologies Market

A strategic analysis of the Transcriptomics Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcriptomics Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Bio-Rad Laboratories, Inc., BioMerieux SA, Cenix BioScience GmbH, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann La Roche Ltd, GenXPro GmbH, Illumina Inc., LC Sciences LLC, Lexogen GmbH, Promega Corporation, Qiagen N. V., Sequentia Biotech SL, Sigma Aldrich Corporation, Takara Holdings, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Transcriptomics Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Gene Regulation Technologies, Microarray, Next Generation Sequencing, and PCR.
• Based on Application, market is studied across Bioinformatics, Clinical Diagnostics, Comparative Transcriptomics, and Drug Discovery & Research.
• Based on End User, market is studied across Academic Research and Pharmaceutical & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing preference for personalized medicines by both manufacturers and end-users
    • 5.1.1.2. Rising prevalence of chronic disorders
    • 5.1.1.3. Approval and launch of new products
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with transcriptomics technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous technological advancements in products
    • 5.1.3.2. Applications of transcriptomics in toxicogenomics
  • 5.1.4. Challenges
    • 5.1.4.1. Data management issues in transcriptomics technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transcriptomics Technologies Market, by Technology

• 6.1. Introduction
• 6.2. Gene Regulation Technologies
• 6.3. Microarray
• 6.4. Next Generation Sequencing
• 6.5. PCR

7. Transcriptomics Technologies Market, by Application

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Clinical Diagnostics
• 7.4. Comparative Transcriptomics
• 7.5. Drug Discovery & Research

8. Transcriptomics Technologies Market, by End User

• 8.1. Introduction
• 8.2. Academic Research
• 8.3. Pharmaceutical & Biotech Companies

9. Americas Transcriptomics Technologies Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Transcriptomics Technologies Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Transcriptomics Technologies Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies Inc.
• 2. Bio-Rad Laboratories, Inc.
• 3. BioMerieux SA
• 4. Cenix BioScience GmbH
• 5. Danaher Corporation
• 6. Eurofins Scientific SE
• 7. F. Hoffmann La Roche Ltd
• 8. GenXPro GmbH
• 9. Illumina Inc.
• 10. LC Sciences LLC
• 11. Lexogen GmbH
• 12. Promega Corporation
• 13. Qiagen N. V.
• 14. Sequentia Biotech SL
• 15. Sigma Aldrich Corporation
• 16. Takara Holdings, Inc.
• 17. Thermo Fisher Scientific Inc.